| 1 | ℹ |
Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.
(linkinghub.elsevier.com)
|
The Lancet 2026-09-29 | #clinical trial #diabetes #obesity #pharmacotherapy | |
| 2 | ℹ |
Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity.
(nejm.org)
|
New England Journal of Medicine 2026-09-29 | #obesity #pharmacotherapy #agonist #metabolism |